Autoantibodies in early rheumatoid arthritis: Brasília cohort - results of a three-year serial analysis
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response | Arthritis Research & Therapy | Full Text
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study | The BMJ
Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis Yarlagadda LD, Jacob R, Rajasekhar D L, Iyyapu KM, S. Kompella SB, Madrol VB, Sreedevi N N, Khan SA,
C-Reactive Protein Level Chart for Rheumatoid Arthritis
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study - The Lancet Rheumatology
An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis | NEJM
High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab | Arthritis Research & Therapy | Full Text
Case 897 --Clinical Immunopathology Case
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study | The BMJ
Rheumatoid factor (RF)
Oman Medical Journal-Archive
Rheumatoid arthritis | Nature Reviews Disease Primers
Article medicale Tunisie, Article medicale Rheumatoid arthritis , Anti-CCP , Rheumatoid factors , Anti-keratin antibodies
PDF) Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis
Diagnostic value of anti-CCP and rheumatoid factor for RA | Download Table
Andrographolide a New Potential Drug for the Long Term Treatment of Rheumatoid Arthritis Disease | IntechOpen
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study | The BMJ
Frontiers | Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity
Rheumatoid Associated Autoantibodies in COVID-19 Patients | JIR
Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis Yarlagadda LD, Jacob R, Rajasekhar D L, Iyyapu KM, S. Kompella SB, Madrol VB, Sreedevi N N, Khan SA,
